Product Information
ENOXAPARIN 150 MG/ML SYRINGE is a generic product labeled by Sanofi-Aventis U.S. LLC, priced at $9.6365 per ML under NDC 00955101510. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Mar 29, 1993. Its Orange Book therapeutic-equivalence code is AP.
The High Outlier badge above means this manufacturer's average price in the enoxaparin sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150 mg/mL
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00955101510
Classification
Generic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
ENOXAPARIN SODIUMApproval Type
Authorized Generic (NDA)
FDA Application
NDA020164FDA Approved
3/29/1993
TE Code
AP
On Market Since
10/3/2011
Pharmacological Classes
Price Statistics
The NADAC for ENOXAPARIN 150 MG/ML SYRINGE has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 83.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.6365 per ML |
|---|---|
| All-time high | $60.7133 (Feb 12, 2014) |
| All-time low | $8.2527 (Nov 20, 2024) |
| 52-week high | $13.0378 |
| 52-week low | $9.6365 |
| Median price | $14.1851 |
| Average price | $19.2770 |
| Largest weekly change | -37.1% (Nov 20, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ENOXAPARIN 150 MG/ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for ENOXAPARIN 150 MG/ML SYRINGE, manufactured by Sanofi-Aventis U.S. LLC, is $9.6365 per ML (NDC 00955101510), effective Aug 19, 2026.
How has the price of ENOXAPARIN 150 MG/ML SYRINGE changed over time?
Over the history we have for it, the NADAC for ENOXAPARIN 150 MG/ML SYRINGE has declined 83.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ENOXAPARIN 150 MG/ML SYRINGE?
Since Nov 28, 2013, the NADAC for ENOXAPARIN 150 MG/ML SYRINGE has ranged from a low of $8.2527 (Nov 20, 2024) to a high of $60.7133 (Feb 12, 2014), with a median of $14.1851 per ML.
Are there cheaper alternatives to ENOXAPARIN 150 MG/ML SYRINGE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ENOXAPARIN 150 MG/ML SYRINGE in a comparable dosage form, but none are currently priced below it.
Who manufactures ENOXAPARIN 150 MG/ML SYRINGE?
ENOXAPARIN 150 MG/ML SYRINGE (NDC 00955101510) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a generic product.